Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 5/20 | 0.67 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PTPRC | P08575 | 1/20 | 0.48 |
| ▸ | S100A4 | P26447 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | CRHBP | P24387 | 2/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PDE2A | O00408 | 1/20 | 0.46 |
| ▸ | PDE5A | O76074 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30648640 | 1.00 | ALDH1A1 (0.68) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL29874193 | 0.83 | ALDH1A1 (0.67) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL113519 | 0.83 | ALDH1A1 (0.67) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL85646 | 0.81 | ALDH1A1 (1.00) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL22529929 | 0.81 | HSPB1 (0.53) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL29351884 | 0.81 | HSPB1 (0.53) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL3277269 | 0.80 | PTPRC (0.54) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL30317899 | 0.80 | PTPRC (0.54) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL384312 | 0.80 | ALDH1A1 (1.00) | ALDH1A1CYP3A4TDP1TSHRACHE | |
| SCHEMBL29511002 | 0.80 | ALDH1A1 (1.00) | ALDH1A1CYP3A4TDP1TSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638615-A | Pyridine-containing terphenyl diamine, colorless transparent polyimide, and preparation methods and applications thereof | 华南理工大学 | 2025-03-18 | — | — | CN | claimed |
| CN-117843499-A | Diamine with asymmetric structure, high-performance polyimide, and preparation methods and applications thereof | 华南理工大学 | 2024-04-09 | — | — | CN | claimed |
| CN-113150273-B | Preparation method of nitrogen-containing polymer | 中国科学院福建物质结构研究所 | 2024-01-23 | — | — | CN | claimed |
| CN-114411169-B | Photoelectrocatalysis hydrogen production and nitroarene in-situ hydrogenation integrated device and application | 山西大学 | 2023-12-26 | — | — | CN | claimed |
| CN-114411169-A | Photoelectrocatalysis hydrogen production and nitro aromatic hydrocarbon in-situ hydrogenation integrated device and application | 山西大学 | 2022-04-29 | — | — | CN | claimed |
| CN-113150273-A | Preparation method of nitrogen-containing polymer | 中国科学院福建物质结构研究所 | 2021-07-23 | — | — | CN | claimed |
| CN-106883175-A | A kind of preparation method of tolvaptan | 天津泰普制药有限公司 | 2017-06-23 | — | — | CN | claimed |
| CN-102219800-B | Organic substituted boric acid ester, boron affinity functional material using organic substituted boric acid ester as functional monomer as well as preparation and application of organic substituted boric acid ester | NANJING UNIVERSITY OF TECHNOLOGY | 2015-02-25 | — | — | CN | claimed |
| CN-102219800-A | Organic substituted boric acid ester, boron affinity functional material using organic substituted boric acid ester as functional monomer as well as preparation and application of organic substituted boric acid ester | NANJING UNIVERSITY OF TECHNOLOGY | 2011-10-19 | — | — | CN | claimed |
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| EP-4711366-A1 | PYRIMIDO MACROHETEROCYCLIC COMPOUND AS WEE1-YES DUAL-TARGET INHIBITOR AND USE THEREOF | Mindrank AI Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| US-12473296-B2 | Perk inhibiting compounds | HIBERCELL, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| EP-4642767-A1 | PYRIMIDINE CARBOXAMIDE COMPOUNDS | Acrivon Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4619406-A1 | TRICYCLIC COMPOUNDS | Schrödinger, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-0396943-A2 | Optical storage medium and storage process | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1990-11-14 | — | — | EP | disclosed |
| US-4957976-A | IMPROVED PROPERTIES FOR AUTOMOBILE TIRES, MODIFIED WITH PHOSPHORYL CHLORIDE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1990-09-18 | — | — | US | disclosed |
| EP-0341496-A2 | Modified diene polymer rubbers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-11-15 | — | — | EP | disclosed |
| EP-0270071-A2 | Process for preparing modified diene polymer rubbers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-06-08 | — | — | EP | disclosed |
| EP-0124283-A1 | Process for the preparation of benzoyl ureas | UNION CARBIDE CORPORATION (US) | 1984-11-07 | — | — | EP | disclosed |
| US-4287372-A | Preparation of nitro-substituted diphenyl ethers | UOP INC. (US) | 1981-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590071-B2 | Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof | ABL1, TH, CYP3A43 | ALDH1A1 1008/4885CYP3A4 27/4885TDP1 2058/4885 |
| US-12473296-B2 | Perk inhibiting compounds | MAPK1, ERN1, MAP3K20 | ALDH1A1 1102/4885CYP3A4 2620/4885TDP1 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.